Video vs. Direct Laryngoscopy for Less Invasive Surfactant Administration
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-3
SponsorUniversity of Texas Southwestern Medical Center
About this trial
Many preterm babies born between 22-28+6 weeks' estimated gestational age (EGA) need surfactant, a medicine that helps the lungs. The goal of the study is to compare the use of video-based visualization to direct visualization during a procedure called less invasive surfactant administration (LISA). The main questions the study aims to answer are: 1) does one method of visualization have a increased rate of giving the medicine successfully on the first attempt? 2) what benefits are there of each method?
Eligibility criteria
Qualifiers
Infants born ≤28 weeks GA successfully resuscitated in the delivery room (DR) and maintained on CPAP • Need for surfactant in the first 36 hours of life based on clinical assessment and/or meeting threshold per unit protocol
Disqualifiers
Infants born ≥29 weeks GA or
Infants with known congenital anomalies or
Infants who are determined by the primary care team to receive comfort care only or
Infants who are intubated at any time prior to surfactant administration
Trial design
Treatments tested in this trial
- Video Laryngoscopy
- Direct Laryngoscopy
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov